NCT07422246

Brief Summary

The purpose of this prospective observational clinical cohort study is to develop a scientifically based approach to the prediction and early diagnosis of intestinal dysfunction in cardiac surgery patients. The main questions that the study should answer: What are the main risk factors for the development of intestinal dysfunction? What specific and non-specific biomarkers can predict the development of intestinal dysfunction? The study participants will be monitored from the moment of hospitalization until the end of their stay in a medical facility

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
28mo left

Started Mar 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Mar 2026Sep 2028

First Submitted

Initial submission to the registry

February 6, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

February 19, 2026

Completed
19 days until next milestone

Study Start

First participant enrolled

March 10, 2026

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2028

Expected
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2028

Last Updated

February 19, 2026

Status Verified

February 1, 2026

Enrollment Period

2.5 years

First QC Date

February 6, 2026

Last Update Submit

February 18, 2026

Conditions

Keywords

cardiac surgeryintestinal dysfunctiongastrointestinal dysfunctiongastrointestinal complicationsmultiorgan dysfunction syndromeintestinal failuregastrointestinal failure

Outcome Measures

Primary Outcomes (2)

  • Identification of markers of intestinal dysfunction:

    Intra-abdominal hypertension of 2 or more degrees and/or gastrostasis (stomach volume \>1.5ml / kg body weight measured no earlier than 4 hours after the last meal); Abdominal compartment syndrome

    During the first 24h after surgery for all patients. On the third, sixth and ninth day, if the patient stay in the ICU

  • The use of pharmacological stimulation of gastrointestinal motility

    During the first 24h after surgery for all patients. On the third, sixth and ninth day, if the patient stay in the ICU

Secondary Outcomes (6)

  • Hospital mortality

    During the first 24h after surgery for all patients. On the third, sixth and ninth day, if the patient stay in the ICU

  • Number of days spent in the ICU

    During the first 24h after surgery for all patients. On the third, sixth and ninth day, if the patient stay in the ICU

  • Total duration of vasopressor support

    During the first 24h after surgery for all patients. On the third, sixth and ninth day, if the patient stay in the ICU

  • The dynamics of the severity of the course on the scale of sequential organ dysfunction (SOFA/SOFA-2) in patients with intestinal dysfunction in the framework of multiorgan dysfunction;

    During the first 24h after surgery for all patients. On the third, sixth and ninth day, if the patient stay in the ICU

  • Total duration of mechanical lung ventilation

    During the first 24h after surgery for all patients. On the third, sixth and ninth day, if the patient stay in the ICU

  • +1 more secondary outcomes

Study Arms (4)

non-complicated patients

EXPERIMENTAL

patients without any complications after cardiac surgery

Diagnostic Test: additional blood testing for specific and non-specific markers of intestinal dysfunction, ultrasound examination of abdominal organs and measurement of intra-abdominal pressure

complicated patients

EXPERIMENTAL

patients with any complications, but without gastrointestinal dysfunction after cardiac surgery

Diagnostic Test: additional blood testing for specific and non-specific markers of intestinal dysfunction, ultrasound examination of abdominal organs and measurement of intra-abdominal pressure

gastrointestinal dysfunction

EXPERIMENTAL

patients with gastrointestinal dysfunction after cardiac surgery

Diagnostic Test: additional blood testing for specific and non-specific markers of intestinal dysfunction, ultrasound examination of abdominal organs and measurement of intra-abdominal pressure

gastrointestinal dysfunction and MODS

EXPERIMENTAL

patients with gastrointestinal dysfunction and MODS after cardiac surgery

Diagnostic Test: additional blood testing for specific and non-specific markers of intestinal dysfunction, ultrasound examination of abdominal organs and measurement of intra-abdominal pressure

Interventions

additional blood testing for specific and non-specific markers of intestinal dysfunction, ultrasound examination of abdominal organs and measurement of intra-abdominal pressure

complicated patientsgastrointestinal dysfunctiongastrointestinal dysfunction and MODSnon-complicated patients

Eligibility Criteria

Age18 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Surgery on the heart and main vessels with a high risk of developing gastrointestinal dysfunction (according to literature data and our own retrospective study);
  • Patient's consent to participate in the study

You may not qualify if:

  • Patient's refusal to participate in the study;
  • HIV infection in the patient;
  • Immunosuppressive therapy;
  • Oncological disease;

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Petrovsky National Research Centre of Surgery

Moscow, Russia

Location

MeSH Terms

Conditions

Intestinal Failure

Condition Hierarchy (Ancestors)

Intestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 6, 2026

First Posted

February 19, 2026

Study Start

March 10, 2026

Primary Completion (Estimated)

September 1, 2028

Study Completion (Estimated)

September 30, 2028

Last Updated

February 19, 2026

Record last verified: 2026-02

Locations